In September of 2019, the Food and Drug Administration (FDA) announced that potentially harmful levels of a cancer-causing agent had been found in products containing ranitidine. These products included heartburn medication Zantac. The long-term use of Zantac had been primarily linked with colorectal cancer, but now a connection has been established between Zantac and breast […]